Literature DB >> 34677656

Pamidronate Therapy Increases Trabecular Bone Complexity of Mandibular Condyles in Individuals with Osteogenesis Imperfecta.

Letícia L Quirino Pantoja1, Mariana Lustosa1, Paulo Márcio Yamaguti1, Lídia S Rosa2, André Ferreira Leite1,3, Paulo Tadeu S Figueiredo1,3, Luiz Claudio Castro4, Ana Carolina Acevedo5,6.   

Abstract

Patients with Osteogenesis Imperfecta (OI) present extra-skeletal manifestations, including important orodental and craniofacial features as dentinogenesis imperfecta, dental agenesis, failure of maxilla growth and hypotonia of masticatory muscles. These features may compromise vital functions speech and mastication. Studies have demonstrated that cyclic pamidronate infusion, the standard therapy for patients with moderate to severe OI, influences the histomorphometric pattern of different body bones. The present study aimed to investigate the condyle trabecular bone pattern in OI patients. We used fractal dimension (FD) analysis on dental panoramic radiographic images to characterize the mandibular condyle trabecular bone in adolescents diagnosed with OI and treated with pamidronate. Imaging exam of 33 adolescents of both sexes, aged between 12 and 17 years, were analyzed and compared with 99 age- and sex-matched healthy adolescents. FD in patients was significantly lower (1.23 ± 0.15) than in healthy controls (1.29 ± 0.11; p < 0.01). Type of OI, age at treatment onset, and the duration of therapy were variables that showed a statistically significant effect on the FD results. This study demonstrated that the bone architecture of mandibular condyles may be altered in pediatric patients with moderate and severe forms of OI. Also, pamidronate treatment seems to have a positive effect on condyle trabecular bone in these patients. This is supported by our finding that FD values were positively influenced by the length of cyclic pamidronate treatment at the time of imaging, as well as by the age of the individual at treatment onset.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bisphosphonates; Cancellous bone; Genetic disease; Mandibular condyle; Osteogenesis imperfecta; Temporomandibular joint

Mesh:

Substances:

Year:  2021        PMID: 34677656     DOI: 10.1007/s00223-021-00915-3

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  30 in total

1.  Static and dynamic bone histomorphometry in children with osteogenesis imperfecta.

Authors:  F Rauch; R Travers; A M Parfitt; F H Glorieux
Journal:  Bone       Date:  2000-06       Impact factor: 4.398

2.  The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta.

Authors:  Frank Rauch; Rose Travers; Horacio Plotkin; Francis H Glorieux
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 3.  Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment.

Authors:  P Trejo; F Rauch
Journal:  Osteoporos Int       Date:  2016-08-05       Impact factor: 4.507

4.  Oral findings in osteogenesis imperfecta.

Authors:  S Schwartz; P Tsipouras
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1984-02

5.  Hyperfibers and vesicles in dentin matrix in dentinogenesis imperfecta (DI) associated with osteogenesis imperfecta (OI).

Authors:  J Waltimo
Journal:  J Oral Pathol Med       Date:  1994-10       Impact factor: 4.253

Review 6.  Osteogenesis imperfecta.

Authors:  Antonella Forlino; Joan C Marini
Journal:  Lancet       Date:  2015-11-03       Impact factor: 79.321

Review 7.  Rare bone diseases and their dental, oral, and craniofacial manifestations.

Authors:  B L Foster; M S Ramnitz; R I Gafni; A B Burke; A M Boyce; J S Lee; J T Wright; S O Akintoye; M J Somerman; M T Collins
Journal:  J Dent Res       Date:  2014-04-03       Impact factor: 6.116

Review 8.  Osteogenesis imperfecta.

Authors:  Joan C Marini; Antonella Forlino; Hans Peter Bächinger; Nick J Bishop; Peter H Byers; Anne De Paepe; Francois Fassier; Nadja Fratzl-Zelman; Kenneth M Kozloff; Deborah Krakow; Kathleen Montpetit; Oliver Semler
Journal:  Nat Rev Dis Primers       Date:  2017-08-18       Impact factor: 52.329

9.  Bisphosphonate Therapy and Tooth Development in Children and Adolescents with Osteogenesis Imperfecta.

Authors:  Barbro Malmgren; Georgios Tsilingaridis; Nina Monsef-Johansson; Zaina Haif Al Qahtani; Göran Dahllöf; Eva Åström
Journal:  Calcif Tissue Int       Date:  2020-05-25       Impact factor: 4.333

10.  Nosology and classification of genetic skeletal disorders: 2019 revision.

Authors:  Geert R Mortier; Daniel H Cohn; Valerie Cormier-Daire; Christine Hall; Deborah Krakow; Stefan Mundlos; Gen Nishimura; Stephen Robertson; Luca Sangiorgi; Ravi Savarirayan; David Sillence; Andrea Superti-Furga; Sheila Unger; Matthew L Warman
Journal:  Am J Med Genet A       Date:  2019-10-21       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.